- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01255826
Ventilatory Management of the Preterm Neonate in the Delivery Room
Ventilatory Management of the Preterm Neonate in the Delivery Room.
Study Overview
Status
Conditions
Detailed Description
Neonatal resuscitation provides lifesaving intervention that, if properly conducted, not only can reduce mortality but probably can significantly decrease subsequent morbidity.
Premature infants need appropriate respiratory support and a lung-protective strategy, starting from the delivery room where, on the contrary, an inadequate respiratory approach may influence pulmonary outcome.
Mechanical ventilation in the form of positive pressure ventilation has remained the mainstay of treatment of respiratory distress syndrome (RDS) in preterm babies. In recent years, a number of new ventilation strategies have been introduced but the problem of bronchopulmonary dysplasia (BPD) has not been solved.
Sustained lung inflation (SLI) lead to a large increase in the tidal volume and the functional residual capacity(FCR) as this intervention may influence the clearance of lung fluids and allow a more even distribution of air throughout the lungs, thus facilitating the formation of FRC.
Nasal CPAP and early PEEP act through stabilization and subsequent recruitment of collapsed alveoli, increased FRC resulting in increased alveolar surface area for gas exchange and a decrease in intrapulmonary shunt .also it conserves endogenous surfactant.
Previous studies with promising results showed that a combination of sustained lung inflation and early nasal CPAP may be the most effective and least injurious way to recruit the lung in preterm neonates at birth.
This study will evaluate sustained lung inflation followed by early nCPAP as delivery room ventilatory management for preterm neonates at risk of respiratory distress syndrome in reducing their need for mechanical ventilation and ameliorating lung injury without inducing adverse effects compared with intermittent bag and mask ventilation.
Study Type
Enrollment (Actual)
Phase
- Phase 2
Contacts and Locations
Study Locations
-
-
-
Cairo, Egypt
- Gynecology and Obstetrics hospital, Ain-Shams University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Preterm infants (gestational age < 34 weeks)
Exclusion Criteria:
1. Neonates with major congenital anomalies (congenital heart disease, neural tube defect, trisomy, etc.).
2.Meconium aspiration syndrome, congenital diaphragmatic hernia and anterior abdominal wall defect.
3.Maternal chorioamnionitis. 4.Neonates with gestational age < 26 weeks and /or birth weight less than 750 grams.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Sustained lung inflation followed by CPAP
Sustained pressure-controlled inflation using a neonatal mask and a T-piece ventilator (NeoPuff Infant Resuscitator; Fisher & Paykel, Auckland, New Zealand). This will be followed by early CPAP. |
After oropharyngeal and nasal suctioning, if there are no signs of spontaneous breathing or breathing is insufficient and/or heart rate is below 100 bpm, the following approach will be followed:Pressure-controlled (20 cm H2O) inflation will be sustained for 15 secs, using a neonatal mask and a T-piece ventilator (NeoPuff Infant Resuscitator; Fisher & Paykel).To avoid pressure leakage, we will use a neonatal mask of appropriate size which adequately cover both the mouth and nostrils of infants.
This pressure controlled inflation will be followed by CPAP at 5 Cm H2O.This procedure will be repeated a second time with a pressure of 25 cm H2O for 15 secs if breathing remained insufficient and/or the heart rate is < 100 bpm and/or the infant is cyanotic.
To be followed by CPAP at 6 Cm H2O.A third puff with a pressure of 30 cm H2O for 15 secs will be used after few seconds if inadequate heart rate and respiration was not reached.
This will be followed by CPAP at 7 Cm H2O.
|
Active Comparator: Conventional self inflating bag and mask ventilation
Intermittent bag and mask ventilation using a self-inflating bag with an oxygen reservoir.
|
After oropharyngeal and nasal suctioning, if there is no signs of spontaneous breathing or breathing is insufficient and/or heart rate is below 100 bpm, intermittent mask and bag ventilation will be administrated at a rate 40-60 per minute using a self-inflating bag and mask with an oxygen reservoir.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Proportionate of neonates in each group who will need endotracheal intubation after failure of positive pressure ventilation through face mask in the delivery room.
Time Frame: 2 minutes
|
2 minutes
|
Need for mechanical ventilation for neonates on nCPAP
Time Frame: 28 days
|
28 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Occurrence and duration of oxygen therapy.
Time Frame: 28 days
|
28 days
|
|
Bronchopulmonary dysplasia (BPD): defined as oxygen requirements more than 28 days.
Time Frame: 28 days
|
28 days
|
|
Pulmonary air leaks
Time Frame: 28 days
|
28 days
|
|
Patent ductus arteriosus (PDA).
Time Frame: 7 days
|
7 days
|
|
Necrotizing enterocolitis (NEC).
Time Frame: 28 days
|
28 days
|
|
Intraventricular hemorrhage (IVH).
Time Frame: 28 days
|
28 days
|
|
Neonatal sepsis.
Time Frame: 28 days
|
28 days
|
|
Length of NICU stay.
Time Frame: 28 days
|
28 days
|
|
Delivery room death or death during admission.
Time Frame: 28 days
|
28 days
|
|
Inflammatory mediators before and after resuscitation
Time Frame: 2 hours
|
Serum Interleukin-1β (IL-1β) and Tumor Necrosis Factor-α (TNF-α)will be measured both initial cord blood before any resuscitation is done and a second time two hours after resuscitation.
|
2 hours
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Mohamed Sami El Shimi, MD, Ain shams university
- Principal Investigator: Hesham Abdel Samie Awad, MD, Ain shams university
- Principal Investigator: Tarek Mohey El Gammacy, MD, Ain shams university
- Principal Investigator: Ola Galal Badr El Deen, MD, Ain shams university
- Principal Investigator: Dina Mohamed Mohamed Shinkar, MSc, Ain shams university
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Dina Shinkar MD protocol
- Sustianed inflation trial (Registry Identifier: Sustianed inflation trial)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Respiratory Distress Syndrome, Newborn
-
Fondazione IRCCS Ca' Granda, Ospedale Maggiore...Dr Anna Lavizzari; Dr Francesca Gaia CiuffiniCompletedNewborn Respiratory Distress SyndromeItaly
-
Third Military Medical UniversityUnknownInfant, Newborn | RDS | Vitamin A | SurfactantChina
-
The First Affiliated Hospital with Nanjing Medical...UnknownRespiratory Distress Syndrome of NewbornChina
-
Assiut UniversityRecruitingNeonatal Respiratory DistressEgypt
-
Groupe Hospitalier Paris Saint JosephCompletedEarly Neonatal Respiratory Distress: Changes in Level IIb Hospital Over a Period of One Year (DROPE)Neonatal Respiratory Distress SyndromeFrance
-
Tanta UniversityRecruitingAcute Lung Injury/Acute Respiratory Distress Syndrome (ARDS) | Respiratory Distress Syndrome, PediatricEgypt
-
Fondazione IRCCS Ca' Granda, Ospedale Maggiore...RecruitingARDS | Respiratory Disease | Pediatric Respiratory Distress SyndromeItaly
-
University of Wisconsin, MadisonUnityPoint Health-MeriterRecruiting
-
Karolinska InstitutetCompletedRespiratory Distress Syndrome, Newborn | Infant, Newborn | Respiratory Insufficiency Syndrome of NewbornSweden
-
Unity Health TorontoRecruitingRespiratory Distress Syndrome | RDS of Prematurity | TTN | Respiratory Distress, NewbornCanada